VECTOR BASED ON AN ADENO-ASSOCIATED VIRUS (AAV) WITH AN HGF HYBRID GENE INSERTED THERETO Russian patent published in 2021 - IPC C12N15/86 C07K14/475 A61K48/00 

FIELD: biotechnology.

SUBSTANCE: described is an expression vector based on an AAV virus (AAV), containing a foreign nucleic acid sequence consisting of a) a nucleotide sequence SEQ ID NO: 5 or b) a codon-modified nucleotide sequence having a homology of sequences at least 80% SEQ ID NO: 5, wherein said codon-modified nucleotide sequence encodes the same amino acid sequence as the coding area SEQ ID NO: 5. Also described is a host cell containing the AAV vector according to claim 1 and producing a protein encoded by the nucleotide sequence SEQ ID NO: 5. Proposed is a composition containing an AAV vector according to claim 1 for prevention or treatment of amyotrophic lateral sclerosis (ALS) or diabetic peripheral neuropathy (DPN).

EFFECT: application of the AAV vector according to the present invention provides a possibility of delivering the HGF hybrid gene to a subject with a high delivery yield.

4 cl, 8 dwg, 1 tbl, 7 ex